
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
This technical note demonstrates a sensitive method for the quantitation of pasireotide in human plasma using high-resolution accurate mass spectrometry. A lower limit of quantitation (LLOQ) of 0.05 ng/mL was achieved in extracted plasma samples.





